Susan S. Jick, DSc

Adjunct Professor, Epidemiology
Susan Jick
(617) 638-7775sjick@bu.edu
Boston Collaborative Drug Surveillance Program
View full profile at BUMC

Biography

Dr. Susan Jick has been in the field of pharmacoepidemiology for over 25 years working with the Boston Collaborative Drug Surveillance Program where she has conducted research in many areas of drug safety. She has been involved with the use and development of large automated databases including the General Practice Research Database which has become a major resource for conducting drug safety studies and has changed the way these studies are being conducted today. Her research activities range from the safety of drugs such as oral contraceptives in relation to venous thrombosis, hormone replacement therapy in relation to cancers, antibiotics in relation to various serious health outcomes, and statins in relation to autoimmune diseases and diabetes, to safety of drug use in the first trimester of pregnancy and use of folic acid to prevent neural tube defects. Dr Jick helps to run a workshop on methods in conducting drug safety studies that is held each year, she teaches the drug epidemiology class at BUSPH and she serves as an advisor to doctoral students in epidemiology.

Education

  • Boston University, MPH
  • Carleton College, BA
  • Boston University, DSc

Publications

  • Published on 10/23/2017

    Li L, Neogi T, Jick S. A cohort study of comorbidity in patients with granulomatosis with polyangiitis. Rheumatology (Oxford). 2017 Oct 23. PMID: 29069513.

    Read at: PubMed
  • Published on 10/13/2017

    Frey N, Bodmer M, Bircher A, Rüegg S, Jick SS, Meier CR, Spoendlin J. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs. Epilepsia. 2017 Oct 13. PMID: 29027197.

    Read at: PubMed
  • Published on 9/15/2017

    Hagberg KW, Jick SS. Validation of autism spectrum disorder diagnoses recorded in the Clinical Practice Research Datalink, 1990-2014. Clin Epidemiol. 2017; 9:475-482. PMID: 28979165.

    Read at: PubMed
  • Published on 7/20/2017

    Bruderer SG, Bodmer D, Stohler NA, Jick SS, Meier CR. Population-Based Study on the Epidemiology of Ménière's Disease. Audiol Neurootol. 2017; 22(2):74-82. PMID: 28723686.

    Read at: PubMed
  • Published on 7/14/2017

    Seliger C, Meier CR, Becker C, Jick SS, Proescholdt M, Bogdahn U, Hau P, Leitzmann MF. Diabetes, use of metformin, and the risk of meningioma. PLoS One. 2017; 12(7):e0181089. PMID: 28708856.

    Read at: PubMed
  • Published on 7/7/2017

    Schneider C, Bodmer M, Jick SS, Meier CR. Colorectal cancer and markers of anemia. Eur J Cancer Prev. 2017 Jul 07. PMID: 28692587.

    Read at: PubMed
  • Published on 6/15/2017

    Jick S, Li L, Gastanaga VM, Liede A, Hernandez RK. Prevalence of hypercalcemia of malignancy among pediatric cancer patients in the UK Clinical Practice Research Datalink database. Clin Epidemiol. 2017; 9:339-343. PMID: 28670142.

    Read at: PubMed
  • Published on 5/29/2017

    Becker C, Jick SS, Meier CR. Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis. Ophthalmology. 2017 Nov; 124(11):1635-1639. PMID: 28571893.

    Read at: PubMed
  • Published on 5/2/2017

    Hagberg KW, Divan HA, Nickel JC, Jick SS. Risk of Incident Antidepressant-Treated Depression Associated with Use of 5a-Reductase Inhibitors Compared with Use of a-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink. Pharmacotherapy. 2017 May; 37(5):517-527. PMID: 28295443.

    Read at: PubMed
  • Published on 5/1/2017

    Becker C, Jick SS, Meier CR, Bodmer M. Metformin and the risk of renal cell carcinoma: a case-control analysis. Eur J Cancer Prev. 2017 May; 26(3):257-262. PMID: 26945286.

    Read at: PubMed

View 254 more publications:View full profile at BUMC

News & In the Media